From a molecular cancer point of view, thrombocytosis has been illustrated to be stimulated by cancer-mediated production of cytokines, most commonly interleukins (IL-1, IL-3, IL-6, and IL-9) and granulocyte-macrophage colony-stimulating factor (GM-CSF). This evidence concerns the gene CSF2 and thrombocytosis disease.